Anove LogoAnove LogoExplAIn
MapsAI frontrunners
Back to Directory

Ibex Prostate

by Ibex Medical Analytics

AI Application
Low Confidence

Ibex Prostate is software for pathology laboratories that analyses digitised whole-slide images of prostate biopsies, used by pathologists. The vendor says its AI highlights suspected cancer as heatmaps, assigns a Gleason grade, takes measurements, flags findings such as perineural invasion, sorts the case worklist, helps pre-order immunohistochemistry and drafts the report. In its IVDR announcement the vendor describes the intended use as supporting pathologists in the primary diagnosis of prostate biopsies, with the AI analysing slides before the pathologist reviews them; the pathologist reviews the AI findings and signs out the diagnosis. It can run inside image-management systems such as Proscia Concentriq. The vendor says its environment is hosted on AWS in a virtual private cloud across several regions, with encryption in transit and at rest, but does not name the regions. In the United States the product is for research use only.

Visit Website

Transparency Score

Weighted across four pillars · updated October 20, 2026

Overall grade
57% weighted
ABCDF
Model
—
Not yet assessed

Capabilities

Prostate Cancer Detection
Gleason Grading
Tumour Measurement
Case Prioritisation
Ihc Preordering
Report Drafting

Vendor Information

Complete information about the vendor/provider of this AI application

Ibex Medical AnalyticsView all products →
Ibex Medical Analytics Ltd.(Trading as: Ibex)
Contact Information
ibex-ai.com
Registered Address
101 Rokach Blvd, Tel Aviv, Tel Aviv District, 6153101, IL

Infrastructure

Platforms hosting this application — each inherits its own transparency grade.

Amazon Web Services (AWS)
Amazon
F
View full infrastructure →

EU AI Act Provider Information

Verification Status:
Unverified
Ibex Medical Analytics Ltd.(Trading as: Ibex)
101 Rokach Blvd, Tel Aviv, Tel Aviv District, 6153101, IL
MedNet EC-REP GmbH
Borkstraße 10, Münster, DE
Compliance Documents
CE Marking: Certified
Ibex states that 'Ibex Prostate is for Research Use Only (RUO) in the United States and not cleared by the FDA' and asks readers to contact it for the indication for use and approval status in other countries (https://ibex-ai.com/ibex-prostate/, read 2026-10-20). Its 2023 IVDR announcement gives the intended use as 'supporting pathologists in primary diagnosis of prostate biopsies' (https://tissuepathology.com/2023/02/14/ibexs-galen-prostate-becomes-first-standalone-ai-powered-cancer-diagnostics-solution-to-obtain-ce-mark-under-the-ivdr/, read 2026-10-20). The website lists no contraindications; the instructions for use are not public.

Supply Chain Network

Visual representation of the vendor's digital supply chain relationships

Compliance & Risk

Get insights into risk by running assessments on this AI application.

Work at Ibex Medical Analytics? Claim this listing to correct or complete the data.

Added: October 20, 2026
Updated: October 20, 2026

Ready to manage AI applications?

Track, assess, and govern your AI applications with Anove.

Anove LogoAnove LogoAnove International B.V.

Helping organizations discover and manage AI applications responsibly. Your trusted source for AI governance and compliance.

Quick Links

  • Browse Directory
  • FAQ
  • AI maps by industry
  • Sign In

Resources

  • Documentation
  • Status
  • Anove.ai

Terms

  • Privacy Policy
  • Terms & Conditions
  • Responsible Disclosure
  • AI Legal Notice
  • Security Policy

© 2026 Anove International B.V. All rights reserved.